In a recent publication of the acute myeloid leukemia (AML) arm of the Tumor Profiler, researchers demonstrated that multi-OMICS profiles can be generated in a clinically meaningful turnaround time ...
When resistance to or failure of hypomethylating agents (HMAs) occurs in acute myeloid leukemia (AML), depleting a ligase ...
Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients with acute myeloid leukemia (AML) with internal tandem duplication in the ...
Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.
Discover how preleukemic stem cells alter the bone marrow microenvironment, promoting leukemia growth. This study reveals key ...
A Valley woman with leukemia hopes to raise awareness about how stem cell donors are needed for transplants that can treat ...
A phase 2/3 study investigating uproleselan with standard 7+3 chemotherapy in newly diagnosed, older patients with acute ...
Aptose Biosciences (TSE:APS) has released an update. Aptose Biosciences is advancing the development of its promising drug tuspetinib as part ...
News Medical on MSN13d
Researchers uncover the link between EVs and tissue damageA landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better ...
The FDA has granted fast track designation to HC-7366 for the treatment of adult patients with relapsed/refractory acute ...
A pioneering Finnish study has shown that drug sensitivity testing can help pinpoint which leukemia patients are likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback